Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma

Journal of Oral Pathology and Medicine

Volumn 28, Issue 2, 1999, Pages 77-81

  Kushner, Jennifer ^a   Bradley, Grace ^a   Young, Beverley ^b   Jordan, Richard C K ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Department of Laboratory Medicine ^*  (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Cancer; Cyclin A; Cyclin B1; Cyclins; Oral

Indexed keywords

EID: 0033080867     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02000.x     Document Type: Article

References (33)

1. COHEN SM, ELLWEIN LB. Cell proliferation in carcinogenesis. Science 1990; 249: 1007-11.
2. WILLIAMS AC, BROWNE SJ, MANNING AM, HAGUE A, VAN DER STAPPEN JW, PARASKEVA C. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis. [Review]. Semin Cancer Biol 1993; 4: 153-9.
3. GIROD SC, KRUEGER G, PAPE HD. p53 and Ki-67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int J Oral Maxillofac Surg 1993; 22: 285-8.
4. WARNAKULASURIYA KA, JOHNSON NW. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 1994; 23: 246-50.
5. CALIFANO J, VAN DER RIET P, WESTRA W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Rex 1996; 56: 2488-92.
6. ANDERSON JA, IRISH JC, MCLACHLIN CM, NGAN BY. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg 1994; 120: 755-60.
7. SOMERS KD, MERRICK MA, LOPEZ ME, INCOGNITO LS, SCHECHTER GL, CASEY G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-4000.
8. OGDEN GR, KIDDIE RA, LUNNY DP, LANE DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 1992; 166: 389-94.
9. SHERR CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5.
10. MURRAY AW. Creative blocks: cell-cycle checkpoints and feedback controls. Nature 1992; 359: 599-604.
11. PINES J. Cyclins, CDKs and cancer. [Review]. Semin Cancer Biol 1995; 6: 63-72.
12. GIRARD F, STRAUSFELD U, FERNANDEZ A, LAMB NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67: 1169-79.
13. HENGLEIN B, CHENIVESSE X, WANG J, EICK D, BRECHOT C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 1994; 91: 5490-4.
14. HOLLOWAY SL, GLOTZER M, KING RW, MURRAY AW. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell 1993; 73: 1393-402.
15. ADELAIDE J, MONGES G, DERDERIAN C, SEITZ JF, BIRNBAUM D. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer 1995; 71: 64-8.
16. BARTKOVA J, LUKAS J, MULLER H, STRAUSS M, GUSTERSON B, BARTEK J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995; 55: 949-56.
17. KOTELNIKOV VM, COON JS, MUNDLE S, et al. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 1997; 3: 95-101.
18. DUTTA A, CHANDRA R, LEITER LM, LESTER S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 1995; 92: 5386-90.
19. MASHAL RD, LESTER S, CORLESS C, et al. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996; 56: 4159-63.
20. WANG J, ZINDY F, CHENIVESSE X, LAMAS E, HENGLEIN B, BRECHOT C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 1992; 7: 1653-6.
21. FURIHATA M, ISHIKAWA T, INOUE A, et al. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 1996; 2: 1781-5.
22. Kìpl in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 1998; 152: 585-90.
23. GERDES J, LEMKE H, BAISCH H, WACKER HH, SCHWAB U, STEIN H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-5.
24. WAHI PN, COHEN B, LUTHRA UK, TORLONI H. Histological typing of oral and oropharyngeal tumours. Geneva: World Health Organization, 1971: 17-8.
25. NORTON AJ, JORDAN S, YEOMANS P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994; 173: 371-9.
26. PINES J, HUNTER T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J 1994; 13: 3772-81.
27. HSU SM, RAINE L, FANGER H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
28. AKERVALL JA, JIN Y, WENNERBERG JP, et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 1995; 76: 853-9.
29. ROSENBERG AR, ZINDY F, LE DEIST F, et al. Overexpression of human cyclin A advances entry into S-phase. Oncogene 1995; 10: 1501-9.
30. GUADAGNO TM, OHTSUBO M, ROBERTS JM, ASSOIAN RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993; 262: 1572-5.
31. DOWNER CS, WATT FM, SPEIGHT PM. Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol 1993; 171: 183-90.
32. cdc2 in the cells of normal, hyperplastic and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol 1996; 178: 422-8.
33. SINCLAIR WK, MORTON RA. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 1966; 450-74.